asdf098

$BMY bouncing off long-term support (4/5)

看多
NYSE:BMY   Bristol-Myers Squibb Company
Conviction: 4/5
might be better to buy when the stock goes over 1998 resistance


General Thesis
  • bouncing off of multi-cycle support (since 1974)
  • Weekly RSI showing sliiight bullish divergence

Growth
  • Margins quite low compared to own history
  • low growth

Value
  • very cheap
    Fundamentals
    low debt/asset ratio and plenty of cash to deal with short term debts

    Potential Risks
  • expensive market...
  • long-term resistance around 76 since 1998

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。